doi: 10.3389/fnut.2024.1433390 Received 15 May 2024 Accepted 30 September 2024 Published 30 October 2024 Volume 11 - 2024 Edited by Anna Maria Aloisi, University of Siena, Italy Reviewed by Vahidreza Ostadmohammadi, Kashan University of Medical Sciences, Iran Anna Petroni, University of Siena, Italy Thomas Herdegen, University of Kiel, Germany Updates Copyright 2024 Hajhashemy, Golpour-Hamedani, Eshaghian, Sadeghi, Khorvash and Askari
Other bowel-related symptoms may include increased flatulence, abdominal bloating, and mild cramping
After 4 weeks dose is increased to inject 0.5cc subcutaneously once a week for another 4 weeks (50 Units on Insulin Syringe) NOTE: We will schedule your 4 week and 7 Week follow up after your consultation so that you can track progress and keep to your dosage schedule
GI side effects (nausea, vomiting, reduced appetite) are expected in the first weeks and at each dose increase: they typically reduce significantly between steps with slow titration Heart rate: a modest increase in resting heart rate is associated with glucagon receptor activation
Both medications support appetite regulation and metabolic health through once-weekly injections, but they operate differently inside the body
albicans can transform itself into an opaque (a/), grey, and gastrointestinally induced transition (GUT) cell to adapt to the changing gastrointestinal environment [8, 13, 14]